Skip to main content
. 2020 Dec 23;68(3):e28857. doi: 10.1002/pbc.28857

TABLE 2.

SARS‐CoV‐2 IgG results in the context of reported symptoms and exposures among a cohort of childhood and young adult survivors followed in NYC

SARS‐CoV‐2 IgG positive SARS‐CoV‐2 IgG negative SARS‐CoV‐2 IgG not reported a All patients
No. (%) No. (%) No. (%) No. (%)
Number of unique patients 20 (6.2) 237 (73.8) 64 (19.9) 321  (100)
History of symptoms 6 (30.0) 24 (10.1) 5 (7.8) 35 (10.9)
Asymptomatic 13 (65.0) 184 (77.6) 28 (43.8) 225 (70.1)
Symptoms not recorded 1 (5.0) 29 (12.2) 30 (48.4) 61 (19.0)
Known exposure 7 (35.0) 12 (5.1) 1 (1.6) 20 (6.2)
No known exposure 12 (60.0) 141 (59.5) 18 (28.1) 171 (53.3)
Exposure not recorded 1 (5.0) 84 (35.4) 44 (70.3) 130 (40.5)
Extended family member death due to COVID‐19 b 1 (5.0) 5 (2.1) 0 (0.0) 6 (1.9)
a

Sixty‐four patients did not have COVID‐19 antibodies drawn due to unordered by provider (n = 35), lab cancellation (n = 15), no indicated screening labs (n = 12), local labs not performed by patient (n = 1), or labs hemolyzed (n = 1).

b

Family member deaths included grandparent (n = 5) and aunt (n = 1).

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.